Clinical Anticoagulation Therapy - Samuel D. Whitaker MD

129,86 €

Spedizione gratuita (Spedizione con raccomandata Spagna)

Pagamento tc Accetta il Pagamento tc

Condizioni del lotto: Molto buono (nuovo o come nuovo, senza segni di utilizzo)

Stampa su richiesta: Questo libro è stampato su richiesta. Il tempo di consegna dipende dalla stampa, che inizia una volta che l'acquirente paga l'ordine.

Autor: Samuel D. Whitaker MD

Editorial: Samuel D. Whitaker MD

Año: 12/10/2026

ISBN: 9782577671043

Encuadernación: Tapa blanda

Páginas: 322 pp.

Idioma: eng

EAN: 9782577671043


Anticoagulation therapy sits at the intersection of hemostasis, thrombosis, cardiovascular medicine, vascular medicine, laboratory diagnostics, and clinical pharmacology. Effective treatment requires more than selecting an anticoagulant; it requires understanding the biological mechanisms that generate and regulate thrombin, recognizing the patient?s competing risks of thrombosis and bleeding, interpreting laboratory data appropriately, and adapting therapy as clinical circumstances change.
This comprehensive reference examines the science and clinical practice of contemporary anticoagulation, beginning with the biology of hemostasis and progressing through coagulation pathophysiology, laboratory evaluation, pharmacology, therapeutic selection, and advanced patient management. It integrates the mechanisms of parenteral and oral anticoagulants with practical approaches to treatment initiation, dose optimization, duration of therapy, monitoring, drug interactions, and long-term management.
Particular attention is given to complex clinical decision-making in venous thromboembolism, atrial fibrillation, mechanical and bioprosthetic heart valves, cerebrovascular disease, critical illness, cancer-associated thrombosis, perioperative care, pregnancy, kidney and liver disease, older adults, and other settings in which conventional treatment strategies require careful modification. The management of major bleeding, anticoagulant-associated complications, reversal therapy, and heparin-induced thrombocytopenia is addressed within the broader framework of risk-benefit assessment.
The book also explores the rapidly evolving science of anticoagulation, including Factor XI and XII inhibition, RNA-based therapeutics, targeted drug delivery, novel reversal technologies, pharmacogenomics, precision medicine, artificial intelligence, and emerging approaches to individualized antithrombotic care. By connecting fundamental coagulation biology with therapeutic reasoning and emerging translational research, it provides a clinically focused framework for understanding how anticoagulation is selected, monitored, adjusted, and advanced.
Designed for clinicians, residents, fellows, pharmacists, and advanced medical students, this work serves as a rigorous resource for developing a deeper understanding of anticoagulant therapy and applying contemporary principles of thrombosis prevention and treatment to increasingly complex patients.
El envío se realizará en 48/72hrs.
avatar Clandestink
Da 13/04/2021
Spagna (Guadalajara)
Venditore registrato come professionista.

Vedi più lotti di Samuel D. Whitaker Md